Sanofi India Limited (SANOFI.BO)

INR 6090.0

(-0.54%)

Operating Expenses Summary of Sanofi India Limited

  • Sanofi India Limited's latest annual operating expenses in 2023 was 3.69 Billion INR , down -45.55% from previous year.
  • Sanofi India Limited's latest quarterly operating expenses in 2024 Q2 was 665 Million INR , down -40.99% from previous quarter.
  • Sanofi India Limited reported a annual operating expenses of 8.73 Billion INR in annual operating expenses 2022, down -5.22% from previous year.
  • Sanofi India Limited reported a annual operating expenses of 9.22 Billion INR in annual operating expenses 2021, down -6.06% from previous year.
  • Sanofi India Limited reported a quarterly operating expenses of 1.12 Billion INR for 2024 Q1, down -16.08% from previous quarter.
  • Sanofi India Limited reported a quarterly operating expenses of 2.21 Billion INR for 2023 Q2, up 4.58% from previous quarter.

Annual Operating Expenses Chart of Sanofi India Limited (2023 - 2004)

Historical Annual Operating Expenses of Sanofi India Limited (2023 - 2004)

Year Operating Expenses Operating Expenses Growth
2023 3.69 Billion INR -45.55%
2022 8.73 Billion INR -5.22%
2021 9.22 Billion INR -6.06%
2020 9.81 Billion INR -10.7%
2019 10.99 Billion INR 2.37%
2018 10.73 Billion INR 4.28%
2017 10.29 Billion INR 19.87%
2016 8.58 Billion INR 5.61%
2015 8.13 Billion INR 9.77%
2014 7.4 Billion INR 10.94%
2013 6.67 Billion INR 9.77%
2012 6.08 Billion INR 32.87%
2011 4.57 Billion INR 47.76%
2010 3.09 Billion INR 23.63%
2009 2.5 Billion INR 1.67%
2008 2.46 Billion INR 35.79%
2007 1.81 Billion INR -11.31%
2006 2.04 Billion INR 6.59%
2005 1.92 Billion INR 3.68%
2004 1.85 Billion INR 0.0%

Peer Operating Expenses Comparison of Sanofi India Limited

Name Operating Expenses Operating Expenses Difference
Abbott India Limited 5.98 Billion INR 38.308%
Cipla Limited 59.21 Billion INR 93.764%
Gland Pharma Limited 3.86 Billion INR 4.366%
GlaxoSmithKline Pharmaceuticals Limited 4.35 Billion INR 15.247%
Kopran Limited 859.54 Million INR -329.644%
Marksans Pharma Limited 3.28 Billion INR -12.268%
NGL Fine-Chem Limited 816.16 Million INR -352.483%
Pfizer Limited 4.33 Billion INR 14.853%
SMS Pharmaceuticals Limited 370.89 Million INR -895.705%